The Max Planck Institute of Biochemistry (MPIB) is a research institute of the Max Planck Society located in Martinsried, a suburb of Munich. The institute was founded in 1973 by the merger of three formerly independent institutes: the Max Planck Institute of Biochemistry, the Max Planck Institute of Protein and Leather Research, and the Max Planck Institute of Cell Chemistry.
Rüdiger Klein is a German neurobiologist. He is director at the Max Planck Institute for Biological Intelligence and head of the department Molecules - Signaling - Development.
Carlos Martínez Alonso, was born in Villasimpliz, in the province of León, on January 9, 1950. In 1974 he obtained a chemistry degree from the Universidad Complutense of Madrid. Four years later, in 1978, he obtained a Ph.D. in immunology by the same university. He was appointed President of the Spanish National Research Council (CSIC) from 2004 to 2008, and Secretary of State for Research in the Ministry of Science and Innovation from early 2008 to December 2009.
The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.
The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.
Ralf Heinrich Adams is a biochemist and cell biologist. He is director at the Max Planck Institute for Molecular Biomedicine and head of the Department of Tissue Morphogenesis in Münster, Germany.
Alfonso Valencia is a Spanish biologist, ICREA Professor, current director of the Life Sciences department at Barcelona Supercomputing Center. and of Spanish National Bioinformatics Institute (INB-ISCIII). From 2015-2018, he was President of the International Society for Computational Biology. His research is focused on the study of biomedical systems with computational biology and bioinformatics approaches.
Max Luciano Birnstiel was a Swiss molecular biologist who held a number of positions in scientific leadership in Europe, including the chair of the Institute of Molecular Biology at the University of Zurich from 1972–86, and that of founding director of the Research Institute of Molecular Pathology (IMP) in Vienna from 1986 to 1996. His research focused on gene regulation in eukaryotes. His research group is sometimes cited as the first to purify single genes, the ribosomal RNA genes from Xenopus laevis, three years before the successful isolation of the lac operon. He is also recognized for one of the earliest discoveries of a gene enhancer element. Birnstiel died in 2014 of heart failure during cancer treatment.
Martin Vingron is an Austrian mathematician working in the fields of bioinformatics and computational biology. Since 2000, he has been Director of the Max Planck Institute for Molecular Genetics.
Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.
Elly Margaret Tanaka is a biochemist and senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. Tanaka studies the molecular cell biology of limb and spinal cord regeneration as well as the evolution of regeneration.
Hartmut Beug (1945–2011) was a German cancer biologist who studied how groups of oncogenes interact to lead to the development and spread of cancer. Shortly before his death, a foundation was set up in his and his wife’s name to support collaboration among young scientists and their studies in the field of metastasis.
Denise P. Barlow was a British geneticist who worked in the field of epigenomics. Barlow was an elected member of European Molecular Biology Organization (EMBO), an honorary professor of genetics at the University of Vienna and recipient of the Erwin Schrödinger Prize of the Austrian Academy of Sciences. In 1991, she discovered the first mammalian imprinted gene, IGF2R, which codes for the insulin-like growth factor.
Tim Clausen is a structural biologist and a senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.
Jan-Michael Peters is a cell- and molecular biologist. Since 2013, he is Scientific Director of the Research Institute of Molecular Pathology (IMP) in Vienna.
Alexander Stark is a biochemist and computational biologist working on the regulation of gene expression in development. He is a senior scientist at the Research Institute of Molecular Pathology (IMP) at the Vienna Biocenter and adjunct professor of the Medical University of Vienna.
Jürgen Knoblich is a German molecular biologist. Since 2018, he is Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Anton Gartner is a geneticist and biologist utilizing the nematode worm Caenorhabditis elegans as a model system He is a distinguished professor at the Ulsan National Institute of Science and Technology (UNIST) in Korea and is one of the two associate directors of the IBS Center for Genomic Integrity located on the UNIST campus.
Axel Behrens is a German-British molecular biologist and an expert in cancer stem cell biology. He is the Scientific Director of the Cancer Research UK Convergence Science Centre in London, a senior group leader at the Institute of Cancer Research and a professor at Imperial College London.
María S. (Marisol) Soengas is a Spanish immunologist who is a professor at the Spanish National Cancer Research Center (CNIO). Her research considers melanoma and the development of new therapeutic strategies. She was elected to the European Molecular Biology Organization in 2022.
